neotiv

Alzheimer’s research and patient-centered digital care

Neotiv Logo
About neotiv

Enabling cognitive health

neotiv GmbH develops digital biomarkers for the early detection of neurodegenerative diseases, first and foremost Alzheimer’s disease. These form the basis for innovative cognitive tests that, embedded in a user-friendly software platform, support the diagnosis and care process.

As a spin-off of Otto-von-Guericke University Magdeburg (OvGU) in close cooperation with the German Center for Neurodegenerative Diseases (DZNE), the company draws on the latest neuroscientific findings.

Management

Dr. Chris Rehse

bmp Ventures Team

Oliver Borrmann

Founded

2017

Invested

2021

Stage

Start-up

Industry

Life Sciences

Status

Aktiv